Search results
Found 20343 matches for
Human trials of new antimalarial drugs are in the pipeline after KEMRI scientists successfully used bacteria to kill the parasite that causes the disease. Trials in Burkina Faso showed that Ivermectin, a conventional drug used for parasitic diseases including river blindness and elephantiasis, reduced transmission rates. The medication worked by making the blood of people who were repeatedly vaccinated lethal to mosquitoes. The study also found that Ivermectin can kill plasmodium falciparum, the malaria parasite carried by female mosquitoes, when administered to humans.
Susanna Dunachie
Principal Investigators Research Scientists
Susanna Dunachie - Professor of Infectious Diseases
Paul Turner
Principal Investigators Research Scientists
MB BS, PhD, FRCPCH, FRCPath Paul Turner - Professor of Paediatric Microbiology
Stuart Blacksell
Principal Investigators Research Scientists
Stuart Blacksell - Professor of Tropical Microbiology
Mehul Dhorda
Research Scientists
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Eduard Sanders
Principal Investigators Research Scientists
Eduard Sanders - Professor of global health practice
Hoa Thi Ngo
MSc IHTM Lecturers Principal Investigators Research Scientists
Hoa Thi Ngo - Associate Professor
Raph Hamers
Principal Investigators Research Scientists
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
David Warrell
Principal Investigators Research Scientists
DM, DSc, FRCP, FRCPE, FMedSci; HonF CeylonCP, RThaiCP, WestAfrCP, CPSMumbai David Warrell - Emeritus Professor of Tropical Medicine
Frank Smithuis
Principal Investigators Research Scientists
Frank Smithuis - Professor of Tropical Medicine
Lorenz Von Seidlein
Principal Investigators Research Scientists
Lorenz Von Seidlein - Professor of Global Health